Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Balaxi Pharmaceuticals Limited ( (IN:BALAXI) ) has shared an update.
Balaxi Pharmaceuticals Limited has announced that a special window has been opened, in accordance with a recent SEBI circular, to allow shareholders holding physical shares to lodge or re-lodge transfer and dematerialisation requests for securities sold or purchased before April 1, 2019. The one-year window runs from February 5, 2026 to February 4, 2027 and covers both fresh lodgements and previously rejected or unattended transfer requests, potentially enabling investors to regularise legacy physical holdings and improve the overall cleanliness and accuracy of the company’s shareholding records.
The company has publicised this facility through newspaper advertisements in English and Telugu and will host the related information on its website, underscoring a push for transparency and regulatory compliance in its capital market interactions. For shareholders, especially those with older or problematic physical certificates, the initiative provides a time-bound opportunity to convert to demat form and resolve documentation deficiencies, which may enhance liquidity and ease of trading while aligning Balaxi’s ownership structure more closely with the broader market shift to electronic securities.
More about Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based pharmaceutical company, with its registered office in Hyderabad, Telangana. The company operates in the pharmaceuticals industry and is listed on the National Stock Exchange of India under the symbol BALAXI, focusing on shareholders who still hold physical share certificates alongside its broader capital market presence.
Balaxi’s investor-facing operations include managing share transfers and dematerialisation processes in line with evolving Securities and Exchange Board of India (SEBI) regulations. By facilitating compliance-oriented share regularisation windows, the company aims to streamline its shareholder registry and support a smoother transition from physical to electronic holdings.
Average Trading Volume: 155,542
Technical Sentiment Signal: Sell
Current Market Cap: 1.38B INR
Find detailed analytics on BALAXI stock on TipRanks’ Stock Analysis page.